IGI Logo

Glenmark Pharmaceuticals is currently trading at Rs. 794.70, up by 2.75 points or 0.35% from its previous closing of Rs. 791.95 on the BSE.

The scrip opened at Rs. 798.85 and has touched a high and low of Rs. 798.90 and Rs. 784.05 respectively. So far 9683 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 832.90 on 27-Jul-2023 and a 52 week low of Rs. 361.70 on 29-Aug-2022.

Last one week high and low of the scrip stood at Rs. 824.65 and Rs. 771.00 respectively. The current market cap of the company is Rs. 22220.74 crore.

The promoters holding in the company stood at 46.65%, while Institutions and Non-Institutions held 34.67% and 18.69% respectively.

Glenmark Pharmaceuticals (Glenmark) has joined hands with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring and solutions for cardiovascular disease management, to raise awareness on measuring blood pressure at home from the age of 18.

Glenmark and OMRON Healthcare India's collaboration, named as ‘Take Charge @18’ initiative, comprises of generating effective communication to enhance awareness around the cause via incorporating an inlay card into every OMRON Blood Pressure monitor sold in India. The message conveys the importance of initiating blood pressure screening at the right age which is 18 years. 

The objective is to encourage patients and care givers who come across this inlay card to sensitize at least four family members of or above the age of 18 to start monitoring their blood pressure and make it a part of their health regime. This message will also be seamlessly integrated into the OMRON Connect app, ensuring it reaches all its subscribers and also on OMRON social media and websites.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.